ALK nominates former Sanofi executive for board membership

Allergy company ALK has nominated Alan Main, former Sanofi Head of Consumer Healthcare, to be its new board member. He will replace Vincent Warnery, who is leaving the board of ALK after being appointed CEO of cosmetics company Beiersdorf.

Nominee for the board of ALK Alan Main | Photo: ALK / PR

Denmark-based allergy and immunotherapy company ALK plans to maintain the company's focus on digital offers such as consumer-oriented services,for which reason it nominates the former head of consumer healthcare at Sanofi, Alan Main, for a place on the board of the firm at the future general meeting, which is scheduled for March next year, according to an ALK press release.

If shareholders formally vote Main into the board, he will be taking over after Vincent Warnery, who was elected for the ALK board in March 2019 with the hopes that he could help boost the consumer healthcare business.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Further reading

Related articles

Trial banner

Latest news

See all jobs